Mark S. MD Gelder - Jun 14, 2021 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
Chief Medical Officer
Signature
/s/ Mark Guerin as attorney-in-fact
Stock symbol
ONTX
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 07:46 PM
Next filing
Aug 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +20K $0.00 20K Jun 14, 2021 Common Stock 20K $7.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Theses options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.